Oxazole compound OxC, derived from industrial, dietary, and intestinal commensal bacteria can impair the lipid antigen presentation function of CD1d in intestinal epithelial cells, reduce IL-10 production, promote iNKT-mediated colon inflammation and can activate the AhR that triggers a CD1d-dependent intestinal inflammatory response. This evidence concerns the gene CD1D and digestive system neoplasm.